Bristol Myers Squibb and Bain Capital Form New Immunology Company

The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb,…

As Coca-Cola prepares to launch a new line of soda sweetened with cane sugar, researchers point out the risks

Coca-Cola says it is launching a new line of soda sweetened with cane sugar.

Merck to Lay Off Workers and Narrows Guidance as Earnings Fall

Merck said it is embarking on a multi-year cost-savings plan, which includes cuts to its workforce…

Health Care Roundup: Market Talk

Find insight on Philips, AstraZeneca and more in the latest Market Talks covering Health Care.

Europe’s Star Economy Picks Up Pace as Fresh Tariff Hikes Loom

Spanish GDP grew 0.7% in the second quarter, a sign of resilience as the eurozone faces…

A Buddhist Monk’s Alleged Indulgence in Money and Sex Transfixes China

An official probe into the jet-setting abbot of China’s Shaolin Temple has fueled cynicism about capitalism…

Famine Is Unfolding in Gaza, U.N.-Backed Group Says

A U.N.-backed group’s finding is the most dire assessment of the enclave’s deepening hunger crisis since…

What’s Israel’s Next Move? Some Call for Full Takeover of Gaza

President Trump has signaled that Israel might have to take a new approach to its war…

U.K. Gives Israel Ultimatum on Palestinian State Recognition

British Prime Minister Keir Starmer said Israel must take “substantive steps” to improve the situation in…

Palo Alto Networks Nears Over $20 Billion Deal for Cybersecurity Firm CyberArk

A deal for the Israeli firm would be the latest in big tech’s cybersecurity consolidation.